T. Quirino

发表

Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group.

A. d’Arminio Monforte, F. Baldanti, F. Ceccherini‐Silberstein, 2012, The new microbiologica.

Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group.

F. Baldanti, F. Ceccherini‐Silberstein, R. Maserati, 2010, The new microbiologica.

Outcome of multidrug-resistant tuberculosis in human immunodeficiency virus-infected patients.

F. Mainini, A. Gori, T. Quirino, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk factors for hepatotoxicity in patients treated with highly active antiretroviral therapy.

E. Ricci, P. Bonfanti, C. Martinelli, 2001, Journal of acquired immune deficiency syndromes.

An Immunological Comparison of Third Companion in Advanced Drug-Naive HIV-Infected Patients

M. Clerici, D. Trabattoni, G. Rizzardini, 2006, HIV clinical trials.

An Italian Approach to Postmarketing Monitoring: Preliminary Results From the SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals) Project on the Safety of Lopinavir/Ritonavir

E. Ricci, P. Bonfanti, G. Parruti, 2005, Journal of acquired immune deficiency syndromes.

Haart Tolerability: Post-Exposure Prophylaxis in Healthcare Workers versus Treatment in HIV-Infected Patients

E. Ricci, P. Bonfanti, T. Quirino, 1999, Antiviral therapy.

Bilateral carotid stenosis in a young female HIV patient treated with highly active antiretroviral therapy

P. Bonfanti, T. Quirino, C. Magni, 2002, AIDS.

Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project

L. Calza, A. Gori, E. Ricci, 2017, PloS one.

Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project.

E. Ricci, P. Bonfanti, T. Quirino, 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients.

C. Viscoli, E. Ricci, P. Bonfanti, 2013, Current HIV research.

Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, The Journal of antimicrobial chemotherapy.

Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?

E. Ricci, P. Bonfanti, L. Taramasso, 2017, Clinics and research in hepatology and gastroenterology.

Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment.

A. d’Arminio Monforte, A. Lazzarin, L. Calza, 2018, The new microbiologica.

Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts

R. Maserati, A. Lazzarin, A. Antinori, 2009, Infection.

Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2013, The Journal of antimicrobial chemotherapy.

Low frequency of skin reactions in a cohort of patients on raltegravir.

A. Antinori, E. Ricci, P. Bonfanti, 2012, The Journal of antimicrobial chemotherapy.

Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART.

E. Ricci, L. Boccassini, M. Carrabba, 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Dossier: Osteoporosis Osteopenia and osteoporosis in HIV+ patients, untreated or receiving

E. Ricci, L. Boccassini, M. Carrabba, 2004 .

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens

Thi Huyen Tram Nguyen, A. d’Arminio Monforte, F. Ceccherini‐Silberstein, 2017, PloS one.

Waist circumference and body mass index in HIV infection

G. Schillaci, E. Ricci, P. Bonfanti, 2011, HIV medicine.

Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real‐Life Cohort Study

A. d’Arminio Monforte, E. Buscarini, P. Lampertico, 2021, Hepatology communications.

Efficacy and safety of boosted and unboosted atazanavir‐containing antiretroviral regimens in real life: results from a multicentre cohort study

E. Gianelli, E. Ricci, P. Bonfanti, 2010, HIV medicine.

Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance.

E. Ricci, P. Bonfanti, A. di Biagio, 2015, International journal of antimicrobial agents.

Long‐term treatment with zidovudine in patients with human immunodeficiency virus (HIV)‐associated thrombocytopenia: Modes of response and correlation with markers of HIV replication

A. Lazzarin, P. Cinque, E. Santagostino, 1993, European journal of haematology.

Low incidence of hepatotoxicity in a cohort of HIV patients treated with lopinavir/ritonavir

E. Ricci, P. Bonfanti, T. Bini, 2005, AIDS.

Class 1 integron-associated spread of resistance regions in Pseudomonas aeruginosa : plasmid or chromosomal platforms ?

A. Antinori, T. Quirino, L. Cordier, 2012 .

Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo study.

A. d’Arminio Monforte, A. Lazzarin, P. Viale, 2014, The new microbiologica.

Osteonecrosis in protease inhibitor-treated patients.

P. Bonfanti, T. Quirino, S. Landonio, 2001, Orthopedics.

Treatment and serological studies of an Italian case of penicilliosis marneffei contracted in Thailand by a drug addict infected with the human immunodeficiency virus

L. Ajello, A. Padhye, L. Kaufman, 2004, European Journal of Epidemiology.

Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study.

G. Schillaci, E. Ricci, P. Bonfanti, 2008, The Journal of infection.

Gender differences in HIV infection: is there a problem? Analysis from the SCOLTA cohorts.

E. Ricci, P. Bonfanti, A. di Biagio, 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role?

S. Babudieri, E. Ricci, K. Falasca, 2016, European journal of gastroenterology & hepatology.

High parathyroid hormone concentration in tenofovir-treated patients are due to inhibition of calcium-sensing receptor activity.

L. Soldati, S. Mora, F. Pivari, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy

A. d’Arminio Monforte, A. Antinori, A. De Luca, 2016, Journal of acquired immune deficiency syndromes.

Early Impairment of Gut Function and Gut Flora Supporting a Role for Alteration of Gastrointestinal Mucosa in Human Immunodeficiency Virus Pathogenesis

M. Clerici, C. Tincati, G. Marchetti, 2007, Journal of Clinical Microbiology.

Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial

M. Clerici, J. Garssen, C. Tincati, 2011, Mucosal Immunology.

Relations between cardiovascular risk estimates and subclinical atherosclerosis in naïve HIV patients: results from the HERMES study

P. Vitiello, E. Ricci, P. Bonfanti, 2010, International journal of STD & AIDS.

Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2018, The Journal of antimicrobial chemotherapy.

Safety and Efficacy of Directly Acting Antivirals in 2432 HCV Patients with Advanced Fibrosis: An Interim Analysis of the Lombardia Regional Network for Viral Hepatitis

G. Filice, M. Colombo, L. Minoli, 2016 .

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, BMC Public Health.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus

A. Lazzarin, L. Calza, V. Vullo, 2018, The Journal of antimicrobial chemotherapy.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study. Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group.

F. Parazzini, P. Bonfanti, C. Martinelli, 2000 .

Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort Study

F. Parazzini, G. Ghiselli, P. Bonfanti, 2000, Journal of acquired immune deficiency syndromes.

Treatment discontinuation in HIV-1-infected individuals starting their first-line HAART after 2008: data from the ICONA Foundation Study Cohort

A. d’Arminio Monforte, A. Antinori, A. De Luca, 2014, Journal of the International AIDS Society.

Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study

D. Francisci, E. Ricci, P. Bonfanti, 2020, BMC Public Health.

Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project).

E. Ricci, P. Bonfanti, A. di Biagio, 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Hypothyroidism in HIV-infected patients who have or have not received HAART.

E. Ricci, E. Chebat, P. Bonfanti, 2004, Clinical Infectious Diseases.

PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection

R. Maserati, G. Nunnari, C. Sagnelli, 2017, PloS one.

Inconsistent condom use among HIV-positive women in the “Treatment as Prevention Era”: data from the Italian DIDI study

A. Monforte, D. Francisci, P. Cicconi, 2013, Journal of the International AIDS Society.

[Renal toxicity in HIV-infected patients receiving HAART including tenofovir].

E. Ricci, P. Bonfanti, T. Quirino, 2006, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

Tossicità renale in pazienti con infezione da HIV in trattamento con HAART contenente tenofovir Renal toxicity in HIV-infected patients receiving HAART includine tenofovir

E. Ricci, P. Bonfanti, T. Quirino, 2006 .

HIV and Metabolic Syndrome: A Comparison With the General Population

G. Mancia, R. Facchetti, M. Bombelli, 2007, Journal of acquired immune deficiency syndromes.

Antiviral Efficacy and Genotypic Resistance Patterns of Combination Therapy with Stavudine/Tenofovir in Highly Active Antiretroviral Therapy Experienced Patients

Stefano Bonora, Stefania Merli, Massimo Andreoni, 2006, Antiviral therapy.

AVT-882 Antinori

A. Antinori, V. Tozzi, M. Andreoni, 2006 .

Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals.

E. Ricci, P. Bonfanti, L. Taramasso, 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study.

L. Calza, G. Pucci, G. Schillaci, 2014, American journal of hypertension.

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2018, BMC Medicine.

Intensive Monitoring of Adverse Drug Reactions in HIV Patients: A Hospital-Based Study in Italy

M. Cosentino, T. Quirino, A. Volonte, 2008 .

The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. C.I.S.A.I. Group.

F. Parazzini, P. Bonfanti, T. Quirino, 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

HIV Clinical Pathway: A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy

A. d’Arminio Monforte, A. Lazzarin, E. Foglia, 2016, PloS one.

Comparison of the efficacy at 48 weeks of first-line antiretroviral treatment for HIV infection in 1998 and 2006: a multicentric investigation

M. D’Alessandro, J. Vecchiet, P. Bonfanti, 2008 .

Chronological and biological age in HIV infection.

E. Ricci, P. Bonfanti, G. Parruti, 2010, The Journal of infection.

Cardiovascular risk assessment in antiretroviral-naïve HIV patients.

E. Ricci, P. Bonfanti, T. Quirino, 2009, AIDS patient care and STDs.

Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group

A. d’Arminio Monforte, F. Baldanti, F. Ceccherini‐Silberstein, 2013, Infection.

HCV novel therapeutic regimens in Wonderland: A budget impact analysis in the Lombardy Region.

E. Foglia, L. Ferrario, D. Croce, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The feature of Metabolic Syndrome in HIV naive patients is not the same of those treated: results from a prospective study.

A. Antinori, E. Ricci, P. Bonfanti, 2012, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Response to First-Line Ritonavir-Boosted Protease Inhibitors (PI/r)-Based Regimens in HIV Positive Patients Presenting to Care with Low CD4 Counts: Data from the Icona Foundation Cohort

Giuliano Rizzardini, Alessandro Cozzi-Lepri, Andrea De Luca, 2016, PloS one.

Metabolic Syndrome: A Real Threat for HIV-Positive Patients?: Results from the SIMONE Study

E. Ricci, P. Bonfanti, G. Parruti, 2006, Journal of acquired immune deficiency syndromes.

Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: results from a multicenter study

E. Ricci, P. Bonfanti, G. Parruti, 2010, Journal of the International AIDS Society.

Risk factors for lipodystrophy in the CISAI cohort.

F. Parazzini, E. Ricci, P. Bonfanti, 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, A. Lazzarin, 2018, HIV medicine.

Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Hypersensitivity reactions during antiretroviral regimens with protease inhibitors.

P. Bonfanti, T. Quirino, L. Testa, 1997, AIDS.

Unusual presentation of acute cytomegalovirus disease during primary HIV-1 infection: antigen-specific T-cell response analyses and clinical outcome.

M. Clerici, D. Trabattoni, T. Quirino, 2006, AIDS.

Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, M. Capobianchi, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Cholesterol levels in HIV-HCV infected patients treated with lopinavir/r: results from the SCOLTA project.

E. Gianelli, E. Ricci, P. Bonfanti, 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.